SCHEMBL18909543

SCHEMBL18909543

C=N/C(=N\C(C)=C/C)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ RAB9A P51151 7/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ GAA P10253 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NAPRT Q6XQN6 1/20 0.38
▸ P4HTM Q9NXG6 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PTBP1 P26599 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13977941 0.74 KDM4E (0.46) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL21953560 0.74 KDM4E (0.48) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL19889808 0.73 KDM4E (0.44) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL18738976 0.72 KDM4E (0.47) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL13977939 0.71 CES2 (0.39) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL20168980 0.70 KDM4E (0.45) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL23343244 0.69 KDM4E (0.52) KDM4EALDH1A1CES2CES1RAB9A
SCHEMBL23838627 0.69 KDM4E (0.38) KDM4EALDH1A1RAB9ASMN1; SMN2GAA
SCHEMBL3729713 0.69 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1RAB9A
Hydrochloric Acid SCHEMBL4201173 0.69 ALDH1A1 (0.59) KDM4EALDH1A1CES2CES1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10367152-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-30 — — US disclosed
WO-2018033610-A1 LIGANDS, ELECTROCHROMIC METALLO-POLYMERS OBTAINED THEREWITH AND THEIR USE JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) 2018-02-22 — — WO disclosed
US-20170155058-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155058-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNE2 KDM4E 2694/4885ALDH1A1 321/4885CES2 1165/4885
US-10367152-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNT1, CCNE2 KDM4E 2694/4885ALDH1A1 321/4885CES2 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback